Name | Relationship | Holdings Value | Past Year Net Change | Change % | Report Date |
---|---|---|---|---|---|
Douglas Carl Fisher | President | $483K | Feb 14, 2024 | ||
Daniel E. Geffken | Chief Financial Officer | $100K | Feb 14, 2024 | ||
Caroline M. Loewy | Director | $58.3K | Feb 14, 2024 | ||
Barbara Kosacz | Director | $58.3K | Feb 14, 2024 | ||
Kathleen Laporte | Director | $0 | Sep 25, 2024 | ||
Christopher B. Ehrlich | Interim Chairman and CEO, Director | $0 | Sep 25, 2024 | ||
Brian Atwood | Director | $0 | Sep 25, 2024 | ||
Andrew Albert Kucharchuk | Chief Financial Officer | Oct 1, 2024 | |||
Charles Carter | Chief Financial Officer | Jun 28, 2024 | |||
Daniel Corey | Chief Technical Officer, Director | Mar 25, 2024 | |||
Robyn Rapaport | Director | Mar 25, 2024 | |||
Lindsey Rolfe | Director | Mar 25, 2024 | |||
Kristen Pierce | Chief Development Officer | Oct 1, 2024 | |||
Michael Byrnes | Director | Mar 25, 2024 | |||
Phoenix Biotech Sponsor, Llc | 10%+ Owner | Feb 14, 2024 |
Insider | Symbol | Class | Transaction | % | Value $ | * Price $ | Shares | Shares Owned | Date | Ownership |
---|